202 related articles for article (PubMed ID: 21078666)
1. The actin-binding protein, actinin alpha 4 (ACTN4), is a nuclear receptor coactivator that promotes proliferation of MCF-7 breast cancer cells.
Khurana S; Chakraborty S; Cheng X; Su YT; Kao HY
J Biol Chem; 2011 Jan; 286(3):1850-9. PubMed ID: 21078666
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel LXXLL motif in α-actinin 4-spliced isoform that is critical for its interaction with estrogen receptor α and co-activators.
Khurana S; Chakraborty S; Zhao X; Liu Y; Guan D; Lam M; Huang W; Yang S; Kao HY
J Biol Chem; 2012 Oct; 287(42):35418-35429. PubMed ID: 22908231
[TBL] [Abstract][Full Text] [Related]
3. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
Band AM; Laiho M
Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
[TBL] [Abstract][Full Text] [Related]
4. Alpha-actinin 4 and tumorigenesis of breast cancer.
Hsu KS; Kao HY
Vitam Horm; 2013; 93():323-51. PubMed ID: 23810014
[TBL] [Abstract][Full Text] [Related]
5. Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors.
Khurana S; Chakraborty S; Lam M; Liu Y; Su YT; Zhao X; Saleem MA; Mathieson PW; Bruggeman LA; Kao HY
J Biol Chem; 2012 Apr; 287(15):12027-35. PubMed ID: 22351778
[TBL] [Abstract][Full Text] [Related]
6. α Actinin 4 (ACTN4) Regulates Glucocorticoid Receptor-mediated Transactivation and Transrepression in Podocytes.
Zhao X; Khurana S; Charkraborty S; Tian Y; Sedor JR; Bruggman LA; Kao HY
J Biol Chem; 2017 Feb; 292(5):1637-1647. PubMed ID: 27998979
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin.
Shao H; Wu C; Wells A
J Biol Chem; 2010 Jan; 285(4):2591-600. PubMed ID: 19920151
[TBL] [Abstract][Full Text] [Related]
8. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.
Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY
J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248
[TBL] [Abstract][Full Text] [Related]
9. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
11. The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.
Chand AL; Wijayakumara DD; Knower KC; Herridge KA; Howard TL; Lazarus KA; Clyne CD
PLoS One; 2012; 7(2):e31593. PubMed ID: 22359603
[TBL] [Abstract][Full Text] [Related]
12. Tyro3-mediated phosphorylation of ACTN4 at tyrosines is FAK-dependent and decreases susceptibility to cleavage by m-Calpain.
Shao H; Wang A; Lauffenburger D; Wells A
Int J Biochem Cell Biol; 2018 Feb; 95():73-84. PubMed ID: 29274473
[TBL] [Abstract][Full Text] [Related]
13. α-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts.
Shao H; Wang JH; Pollak MR; Wells A
PLoS One; 2010 Nov; 5(11):e13921. PubMed ID: 21085685
[TBL] [Abstract][Full Text] [Related]
14. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
Laganière J; Deblois G; Giguère V
Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor-dependent regulation of CYP2B6 in human breast cancer cells.
Lo R; Burgoon L; Macpherson L; Ahmed S; Matthews J
Biochim Biophys Acta; 2010; 1799(5-6):469-79. PubMed ID: 20079471
[TBL] [Abstract][Full Text] [Related]
16. A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactions.
Herynk MH; Hopp T; Cui Y; Niu A; Corona-Rodriguez A; Fuqua SA
Breast Cancer Res Treat; 2010 Jul; 122(2):381-93. PubMed ID: 19842032
[TBL] [Abstract][Full Text] [Related]
17. Alpha-actinin 4 potentiates myocyte enhancer factor-2 transcription activity by antagonizing histone deacetylase 7.
Chakraborty S; Reineke EL; Lam M; Li X; Liu Y; Gao C; Khurana S; Kao HY
J Biol Chem; 2006 Nov; 281(46):35070-80. PubMed ID: 16980305
[TBL] [Abstract][Full Text] [Related]
18. Estrogenically regulated LRP16 interacts with estrogen receptor alpha and enhances the receptor's transcriptional activity.
Han WD; Zhao YL; Meng YG; Zang L; Wu ZQ; Li Q; Si YL; Huang K; Ba JM; Morinaga H; Nomura M; Mu YM
Endocr Relat Cancer; 2007 Sep; 14(3):741-53. PubMed ID: 17914104
[TBL] [Abstract][Full Text] [Related]
19. AIB1 sequestration by androgen receptor inhibits estrogen-dependent cyclin D1 expression in breast cancer cells.
De Amicis F; Chiodo C; Morelli C; Casaburi I; Marsico S; Bruno R; Sisci D; Andò S; Lanzino M
BMC Cancer; 2019 Nov; 19(1):1038. PubMed ID: 31684907
[TBL] [Abstract][Full Text] [Related]
20. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators.
Jaber BM; Gao T; Huang L; Karmakar S; Smith CL
Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
